Inflammation and TGF-β Signaling Differ between Abdominal Aneurysms and Occlusive Disease

Area of Science:

• Vascular Biology
• Genomics
• Molecular Medicine

Background:

• Abdominal aortic aneurysms (AAA) are a significant cause of fatal bleeding, often linked to cardiovascular risk factors.
• Despite similar atherosclerotic burden, AAA and arterial occlusive disease (AOD) present differently (dilatation vs. occlusion), with unknown molecular drivers.
• Understanding these molecular mechanisms is crucial for improving AAA treatment strategies.

Purpose of the Study:

• To identify novel genes and signaling pathways involved in the pathogenesis of abdominal aortic aneurysms.
• To compare gene expression profiles between AAA and AOD patients to uncover disease-specific molecular signatures.
• To discover potential blood biomarkers or therapeutic targets for AAA.

Main Methods:

• Comparative analysis of RNA expression profiles from abdominal aortic aneurysm (AAA) and arterial occlusive disease (AOD) patient samples.
• Differential gene expression analysis to identify a candidate gene set.
• Pathway analysis to investigate altered signaling cascades in AAA.

Main Results:

• Identification of previously known AAA-associated genes (COL11A1, ADIPOQ, LPL) and novel genes (CXCL13, SLC7A5, FDC-SP).
• Significant enrichment of immune-related pathways in AAA compared to AOD.
• Observed inhibition of bone morphogenetic protein (BMP) signaling concurrent with activation of transforming growth factor β (TGF-β) signaling in AAA.

Conclusions:

• Gene expression profiling effectively identifies novel genes implicated in AAA.
• A unique interplay between BMP and TGF-β signaling pathways is specifically associated with abdominal aortic aneurysms.
• The identified genes and pathways offer potential targets for future AAA biomarkers and therapies.